Obstacles from the synchroneity of Dengue and Corona virus infections
DOI:
https://doi.org/10.46568/bios.v4i1.120Keywords:
Dengue, Corona virus, MosquitoReferences
Harapan H, Ryan M, Yohan B, Abidin RS, Nainu F, Rakib A, et al. Covid-19 and dengue: Double punches for dengue-endemic countries in Asia. Rev Med Virol 2021; 31(2): e2161.
World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19-11 2020.
Malavige GN, Jeewandara C, Ogg GS. Dengue and COVID-19: two sides of the same coin. J Biomed Sci 2022; 29(1): 48.
Osuna-Ramos JF, Reyes-Ruiz JM, Ochoa-Ramírez LA, De Jesús-González LA, Ramos-Payán R, Farfan-Morales CN, et al. The usefulness of peripheral blood cell counts to distinguish COVID-19 from dengue during acute infection. Trop Med Infect Dis 2022; 7: 20.
Santoso MS, Masyeni S, Haryanto S, Yohan B, Hibberd ML, Sasmono RT. Assessment of dengue and COVID-19 antibody rapid diagnostic tests cross-reactivity in Indonesia. Virol J 2021; 18(1): 1-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 BioSight
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright in their published work and grant BioSight the right of first publication.
All articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits others to read, download, copy, distribute, print, search, link to, adapt, and build upon the work for any lawful purpose, including commercial use, provided that appropriate credit is given to the author(s) and BioSight, a link to the license is provided, and any changes are clearly indicated.
Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of their work, provided that its initial publication in BioSight is acknowledged.
Publication in BioSight does not require authors to transfer copyright to the journal or publisher.
